Adequan® i.m. is an FDA pioneer drug that has no generic, and there is no product that is "just like Adequan only cheaper."
A 'generic' drug is bioequivalent to a pioneer drug in dosage form, efficacy, safety and strength, route of administration,
quality, and intended use. Adequan i.m. is the ONLY FDA-Approved polysulfated glycosaminoglycan (PSGAG) for the intramuscular
treatment of non-infectious degenerative joint disease (DJD) of the carpal and hock joints.